Center for Pharmaceutical Policy and Prescribing
@pittcp3.bsky.social
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
Pinned
👋Greetings to our new followers! CP3 conducts research to inform the regulation, coverage, & equitable access of #pharmaceuticals & improving patient & prescriber decision-making on #prescriptiondrugs.
Get to know our work & join our mailing list: www.cp3.pitt.edu
#healthpolicy #rxsky #medsky
Get to know our work & join our mailing list: www.cp3.pitt.edu
#healthpolicy #rxsky #medsky
Have you heard of Pitt's Healthy Home Lab? It's one of the innovations led by our parent org, Pitt's Health Policy Institute. In @publicsource.org, read about it and other solutions to help older adults:
www.publicsource.org/pennsylvania...
www.publicsource.org/pennsylvania...
From singing robots to living laboratories, care leaders seek solutions to aging Pittsburgh’s needs
Aging populations in Western Pennsylvania and assisted living staffing shortages prompt tech innovations and workforce development efforts.
www.publicsource.org
November 13, 2025 at 7:31 PM
Have you heard of Pitt's Healthy Home Lab? It's one of the innovations led by our parent org, Pitt's Health Policy Institute. In @publicsource.org, read about it and other solutions to help older adults:
www.publicsource.org/pennsylvania...
www.publicsource.org/pennsylvania...
ICYMI: CP3's @bryantshuey.bsky.social was recently chosen as a @nam.edu State Health Policy Fellow. Dr. Shuey will use his expertise in addiction issues to advise the PA Department of Health's Office of Drug Surveillance and Misuse Prevention.
www.medschool.pitt.edu/news/bryant-...
www.medschool.pitt.edu/news/bryant-...
Bryant Shuey Chosen for State Health Policy Fellowship | School of Medicine | University of Pittsburgh
Bryant Shuey, assistant professor of medicine, University of Pittsburgh, is one of five fellows selected for the National Academy of Medicine (NAM)’s State Health Policy Fellowship (SHPF) program anno...
www.medschool.pitt.edu
November 10, 2025 at 2:14 PM
ICYMI: CP3's @bryantshuey.bsky.social was recently chosen as a @nam.edu State Health Policy Fellow. Dr. Shuey will use his expertise in addiction issues to advise the PA Department of Health's Office of Drug Surveillance and Misuse Prevention.
www.medschool.pitt.edu/news/bryant-...
www.medschool.pitt.edu/news/bryant-...
🆕editorial co-authored by CP3’s Dr. Julie Donohue argues that as health policy enters a turbulent era, research must focus not only on access, cost, & quality, but also on system innovations, SDoH, & emerging tools like AI.
@jamahealthforum.com:
jamanetwork.com/journals/jam...
@jamahealthforum.com:
jamanetwork.com/journals/jam...
November 5, 2025 at 2:09 PM
🆕editorial co-authored by CP3’s Dr. Julie Donohue argues that as health policy enters a turbulent era, research must focus not only on access, cost, & quality, but also on system innovations, SDoH, & emerging tools like AI.
@jamahealthforum.com:
jamanetwork.com/journals/jam...
@jamahealthforum.com:
jamanetwork.com/journals/jam...
🆕study co-authored by CP3’s Dr. Bernie Good finds that a targeted pharmacy-care-management service ⬆️💊 adherence & ⬇️resource use among Medicare Advantage beneficiaries—supporting broader use of pharmacist-led models in managing cardiometabolic conditions.
Read more: www.jmcp.org/doi/10.18553...
Read more: www.jmcp.org/doi/10.18553...
November 3, 2025 at 3:57 PM
🆕study co-authored by CP3’s Dr. Bernie Good finds that a targeted pharmacy-care-management service ⬆️💊 adherence & ⬇️resource use among Medicare Advantage beneficiaries—supporting broader use of pharmacist-led models in managing cardiometabolic conditions.
Read more: www.jmcp.org/doi/10.18553...
Read more: www.jmcp.org/doi/10.18553...
New study co-authored by CP3’s Dr. Katie Suda found repeat C. difficile testing within 7 days was uncommon (4.5%) but more frequent in long-term care and among resident-ordered tests—highlighting opportunities to strengthen diagnostic stewardship.
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
October 30, 2025 at 3:41 PM
New study co-authored by CP3’s Dr. Katie Suda found repeat C. difficile testing within 7 days was uncommon (4.5%) but more frequent in long-term care and among resident-ordered tests—highlighting opportunities to strengthen diagnostic stewardship.
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
New study from CP3 finds buprenorphine initiation in older adults rose in 2018–19 but plateaued thru 2021 despite access efforts—showing need for targeted implementation & clinician education to boost MOUD use.
@agsjournal.bsky.social
agsjournals.onlinelibrary.wiley.com/doi/full/10....
@agsjournal.bsky.social
agsjournals.onlinelibrary.wiley.com/doi/full/10....
October 27, 2025 at 1:33 PM
New study from CP3 finds buprenorphine initiation in older adults rose in 2018–19 but plateaued thru 2021 despite access efforts—showing need for targeted implementation & clinician education to boost MOUD use.
@agsjournal.bsky.social
agsjournals.onlinelibrary.wiley.com/doi/full/10....
@agsjournal.bsky.social
agsjournals.onlinelibrary.wiley.com/doi/full/10....
New study co-authored by CP3’s Dr. Katie Suda & Yilei Liu found that 1 in 10 pediatric dental visits involving opioids led to overdose or persistent use—highest in young children. Highlights need for caution and nonopioid pain management. pubmed.ncbi.nlm.nih.gov/41081662/
October 23, 2025 at 2:19 PM
New study co-authored by CP3’s Dr. Katie Suda & Yilei Liu found that 1 in 10 pediatric dental visits involving opioids led to overdose or persistent use—highest in young children. Highlights need for caution and nonopioid pain management. pubmed.ncbi.nlm.nih.gov/41081662/
New study co-authored by CP3’s Dr. Katie Suda found that antibiotic durations for common infections in older adults are often longer than guidelines recommend, highlighting opportunities to reduce overuse and improve antimicrobial stewardship.
pubmed.ncbi.nlm.nih.gov/41050542/
pubmed.ncbi.nlm.nih.gov/41050542/
October 21, 2025 at 5:06 PM
New study co-authored by CP3’s Dr. Katie Suda found that antibiotic durations for common infections in older adults are often longer than guidelines recommend, highlighting opportunities to reduce overuse and improve antimicrobial stewardship.
pubmed.ncbi.nlm.nih.gov/41050542/
pubmed.ncbi.nlm.nih.gov/41050542/
New study co-authored by CP3’s Dr. Tom Radomski finds standard criteria for medication appropriateness may not align w/shifting goals of care in dementia. Integrating goals-of-care data could improve 💊optimization.
More @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
More @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
October 17, 2025 at 2:23 PM
New study co-authored by CP3’s Dr. Tom Radomski finds standard criteria for medication appropriateness may not align w/shifting goals of care in dementia. Integrating goals-of-care data could improve 💊optimization.
More @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
More @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Congratulations to our colleague @mirandayaver.bsky.social for being named one of the @academyhealth.bsky.social Champions for Health Services & Prevention Research! Well deserved!
academyhealth.org/page/champio...
academyhealth.org/page/champio...
Champions for Health Services and Prevention Research | AcademyHealth
academyhealth.org
October 16, 2025 at 2:55 PM
Congratulations to our colleague @mirandayaver.bsky.social for being named one of the @academyhealth.bsky.social Champions for Health Services & Prevention Research! Well deserved!
academyhealth.org/page/champio...
academyhealth.org/page/champio...
ICYMI, the PROTECT project, w/CP3’s @jennylociganic.bsky.social & @walidgellad.bsky.social as co-investigators, secured a NIH/NIDA grant to build an #AI clinical tool for predicting relapse in #buprenorphine patients.
@pittgim.bsky.social @pittdeptofmed.bsky.social
pharmacy.ufl.edu/2025/10/09/a...
@pittgim.bsky.social @pittdeptofmed.bsky.social
pharmacy.ufl.edu/2025/10/09/a...
AI-powered clinical tool aims to prevent opioid disorder relapse » College of Pharmacy » University of Florida
The PROTECT tool employs machine learning algorithms to predict a patient’s risk of relapse.
pharmacy.ufl.edu
October 15, 2025 at 2:38 PM
ICYMI, the PROTECT project, w/CP3’s @jennylociganic.bsky.social & @walidgellad.bsky.social as co-investigators, secured a NIH/NIDA grant to build an #AI clinical tool for predicting relapse in #buprenorphine patients.
@pittgim.bsky.social @pittdeptofmed.bsky.social
pharmacy.ufl.edu/2025/10/09/a...
@pittgim.bsky.social @pittdeptofmed.bsky.social
pharmacy.ufl.edu/2025/10/09/a...
🆕study co-authored by CP3’s @timandersonmd.bsky.social describes a psychologist-led mindfulness-informed CBT program designed to complement pharmacist support in helping older adults reduce or stop benzos. Next step: testing feasibility in a pilot trial.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
October 13, 2025 at 2:57 PM
🆕study co-authored by CP3’s @timandersonmd.bsky.social describes a psychologist-led mindfulness-informed CBT program designed to complement pharmacist support in helping older adults reduce or stop benzos. Next step: testing feasibility in a pilot trial.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
Congrats to CP3's @bryantshuey.bsky.social for being selected as a @nam.edu State Health Policy Fellow! He'll gain even more experience in advising state policymakers to improve health in PA.
nam.edu/news-and-ins...
@pittgim.bsky.social @pittdeptofmed.bsky.social
nam.edu/news-and-ins...
@pittgim.bsky.social @pittdeptofmed.bsky.social
October 10, 2025 at 2:11 PM
Congrats to CP3's @bryantshuey.bsky.social for being selected as a @nam.edu State Health Policy Fellow! He'll gain even more experience in advising state policymakers to improve health in PA.
nam.edu/news-and-ins...
@pittgim.bsky.social @pittdeptofmed.bsky.social
nam.edu/news-and-ins...
@pittgim.bsky.social @pittdeptofmed.bsky.social
New preprint co-authored by CP3’s @jennylociganic.bsky.social: PGx can help match patients to safer opioids. An ensemble ML model (XGB+SVM-RBF) best predicted PGx uptake (AUC 79.6%). With further validation, it could support real-world clinical decision tools. www.medrxiv.org/content/10.1...
October 2, 2025 at 6:23 PM
New preprint co-authored by CP3’s @jennylociganic.bsky.social: PGx can help match patients to safer opioids. An ensemble ML model (XGB+SVM-RBF) best predicted PGx uptake (AUC 79.6%). With further validation, it could support real-world clinical decision tools. www.medrxiv.org/content/10.1...
New study co-authored by CP3’s Dr. Ted Park finds over 1 in 5 opioid/benzo-naïve patients started 🆕Rx after surgery, while half with prior use continued. Many fills reflect preexisting use—highlighting need for tailored risk management.
More @acsjacs.bsky.social:
journals.lww.com/journalacs/a...
More @acsjacs.bsky.social:
journals.lww.com/journalacs/a...
September 30, 2025 at 2:58 PM
New study co-authored by CP3’s Dr. Ted Park finds over 1 in 5 opioid/benzo-naïve patients started 🆕Rx after surgery, while half with prior use continued. Many fills reflect preexisting use—highlighting need for tailored risk management.
More @acsjacs.bsky.social:
journals.lww.com/journalacs/a...
More @acsjacs.bsky.social:
journals.lww.com/journalacs/a...
🆕study in 🫀co-authored by CP3’s @timandersonmd.bsky.social examines acute ⬆️ #bloodpressure in hospital settings. Clinicians often don’t treat it, citing uncertainty about dx thresholds & risks—highlighting need for clearer guidelines & decision support tools.
More: heart.bmj.com/content/earl...
More: heart.bmj.com/content/earl...
September 26, 2025 at 3:09 PM
🆕study in 🫀co-authored by CP3’s @timandersonmd.bsky.social examines acute ⬆️ #bloodpressure in hospital settings. Clinicians often don’t treat it, citing uncertainty about dx thresholds & risks—highlighting need for clearer guidelines & decision support tools.
More: heart.bmj.com/content/earl...
More: heart.bmj.com/content/earl...
New study co-authored by CP3’s Dr. Coleman Drake finds that a 2008 federal #methadone supply restriction led patients to switch to safer formulations, preventing an estimated 1,600 #overdose deaths over two years.
Read more: www.sciencedirect.com/science/arti...
Read more: www.sciencedirect.com/science/arti...
September 25, 2025 at 1:14 PM
New study co-authored by CP3’s Dr. Coleman Drake finds that a 2008 federal #methadone supply restriction led patients to switch to safer formulations, preventing an estimated 1,600 #overdose deaths over two years.
Read more: www.sciencedirect.com/science/arti...
Read more: www.sciencedirect.com/science/arti...
We’re excited to share the launch of CP3’s new website, now hosted on the @openscholar.bsky.social platform! The site offers a fresh, unified look with other Pitt Centers and Institutes and is designed to spotlight CP3’s research projects.
Take a look!
cp3.pitt.edu
Take a look!
cp3.pitt.edu
Center for Pharmaceutical Policy and Prescribing
The Center for Pharmaceutical Policy and Prescribing (CP3) at the University of Pittsburgh is a multidisciplinary hub connecting faculty to advance pharmacoepidemiology research and machine learning–b...
cp3.pitt.edu
September 24, 2025 at 12:29 PM
We’re excited to share the launch of CP3’s new website, now hosted on the @openscholar.bsky.social platform! The site offers a fresh, unified look with other Pitt Centers and Institutes and is designed to spotlight CP3’s research projects.
Take a look!
cp3.pitt.edu
Take a look!
cp3.pitt.edu
🆕preprint co-authored by CP3’s Dr. Julie Donohue finds ACA #Medicaid expansion in NJ & PA led to large immediate increases in Medicaid enrollment among people using homelessness assistance services, especially those with frequent service contact.
www.researchsquare.com/article/rs-6...
www.researchsquare.com/article/rs-6...
September 23, 2025 at 12:43 PM
🆕preprint co-authored by CP3’s Dr. Julie Donohue finds ACA #Medicaid expansion in NJ & PA led to large immediate increases in Medicaid enrollment among people using homelessness assistance services, especially those with frequent service contact.
www.researchsquare.com/article/rs-6...
www.researchsquare.com/article/rs-6...
🆕study w/ CP3 co-authors shows prescribers responded to the 2018-19 ARB (valsartan, losartan, irbesartan) recalls with large reductions in valsartan fills (↓ 57-59%), offset by increases in other ARBs. No major shift toward non-ARB antihypertensives.
journals.lww.com/lww-medicalc...
journals.lww.com/lww-medicalc...
September 22, 2025 at 2:02 PM
🆕study w/ CP3 co-authors shows prescribers responded to the 2018-19 ARB (valsartan, losartan, irbesartan) recalls with large reductions in valsartan fills (↓ 57-59%), offset by increases in other ARBs. No major shift toward non-ARB antihypertensives.
journals.lww.com/lww-medicalc...
journals.lww.com/lww-medicalc...
🆕analysis led by CP3's Dr. Katie Suda & Tate Miner & team shows National Action Plan implementation wasn't associated with changes in antibiotic sales after 2 years.
@mina-t.bsky.social @pittgim.bsky.social
Read more @ichejournal.bsky.social:
www.cambridge.org/core/journal...
@mina-t.bsky.social @pittgim.bsky.social
Read more @ichejournal.bsky.social:
www.cambridge.org/core/journal...
September 19, 2025 at 1:09 PM
🆕analysis led by CP3's Dr. Katie Suda & Tate Miner & team shows National Action Plan implementation wasn't associated with changes in antibiotic sales after 2 years.
@mina-t.bsky.social @pittgim.bsky.social
Read more @ichejournal.bsky.social:
www.cambridge.org/core/journal...
@mina-t.bsky.social @pittgim.bsky.social
Read more @ichejournal.bsky.social:
www.cambridge.org/core/journal...
New @journalgim.bsky.social study: VA clinicians cite evidence uncertainty, patient expectations, and system barriers as drivers of low-value care. Clearer guidance, education & aligned incentives may help reduce it.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
September 18, 2025 at 2:21 PM
New @journalgim.bsky.social study: VA clinicians cite evidence uncertainty, patient expectations, and system barriers as drivers of low-value care. Clearer guidance, education & aligned incentives may help reduce it.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
🆕paper, co-authored by CP3's @timandersonmd.bsky.social, describes findings that inpatient orthostatic hypotension was most often recognized after admission, but etiology and management differed across service lines.
Read more: onlinelibrary.wiley.com/doi/10.1111/...
Read more: onlinelibrary.wiley.com/doi/10.1111/...
September 16, 2025 at 4:54 PM
🆕paper, co-authored by CP3's @timandersonmd.bsky.social, describes findings that inpatient orthostatic hypotension was most often recognized after admission, but etiology and management differed across service lines.
Read more: onlinelibrary.wiley.com/doi/10.1111/...
Read more: onlinelibrary.wiley.com/doi/10.1111/...
New analysis suggests restrictive state #opioid treatment program regulations limit geographic access to #methadone maintenance treatment & easing these restrictions could expand access.
Read more in Health Affairs:
www.healthaffairs.org/doi/10.1377/...
Read more in Health Affairs:
www.healthaffairs.org/doi/10.1377/...
September 15, 2025 at 3:15 PM
New analysis suggests restrictive state #opioid treatment program regulations limit geographic access to #methadone maintenance treatment & easing these restrictions could expand access.
Read more in Health Affairs:
www.healthaffairs.org/doi/10.1377/...
Read more in Health Affairs:
www.healthaffairs.org/doi/10.1377/...
Though there were no differences in ED use or all-cause mortality, #Medicaid prescription cap policies were associated with increased hospitalization risk.
Read more: www.sciencedirect.com/science/arti...
Read more: www.sciencedirect.com/science/arti...
September 11, 2025 at 12:44 PM
Though there were no differences in ED use or all-cause mortality, #Medicaid prescription cap policies were associated with increased hospitalization risk.
Read more: www.sciencedirect.com/science/arti...
Read more: www.sciencedirect.com/science/arti...